Cui et al. Sig Transduct Target Ther 7, 334 (2022).
The epitranscriptome—the collection of chemical modifications that decorate RNA molecules—adds a dynamic and complex layer of regulation to gene expression. More than 170 distinct RNA modifications have been catalogued, but until recently our ability to map these modifications was limited to bulk samples, obscuring the underlying cellular heterogeneity. Advances in single‑cell RNA sequencing (scRNA‑seq) coupled with bespoke chemical or enzymatic methods now permit the detection of epitranscriptomic marks at or near single‑base resolution in individual cells. This review summarises the current state of experimental approaches for profiling four of the most prevalent and functionally important modifications—N6‑methyladenosine (m6A), 5‑methylcytosine (m5C), pseudouridine (Ψ) and adenosine‑to‑inosine (A‑to‑I) editing—alongside the bioinformatic tools required to analyse such data. We highlight how these technologies are revealing the role of RNA modifications in development, ageing, host–pathogen interactions and across the tree of life, and we discuss the remaining technical and computational challenges that must be overcome to fully interpret the single‑cell epitranscriptome.
1 Single
Cell Epitranscriptome Profiling: Basics
RNA molecules are not just passive
messengers between DNA and protein. They are sculpted by a diverse set of
chemical modifications that influence splicing, export, stability and
translation. Collectively these marks constitute the epitranscriptome, a
regulatory layer that is installed by writers, removed by erasers
and interpreted by reader proteins. Although more than 170 modifications
have been described, the majority of functional knowledge comes from abundant
RNA species such as tRNAs and rRNAs because their high copy number facilitated
early mapping efforts. Internal modifications on messenger RNAs (mRNAs)—notably
m6A, m5C, Ψ and A‑to‑I editing—were reported
decades ago but only became accessible to high‑throughput studies with the
advent of next‑generation sequencing technologies. The distribution of m6A, for example, is biased toward
the 3′ untranslated region and near the stop codon, underscoring the importance of precise localisation for
understanding function.
Bulk epitranscriptomic studies
average signals across thousands or millions of cells, masking cell‑to‑cell
variability. In tissues with complex cellular compositions this averaging can
confound interpretation—for instance, an apparent change in modification level might
reflect a shift in cell‑type proportions rather than altered modification
dynamics. By integrating scRNA‑seq with epitranscriptomic detection,
researchers can now deconvolve this heterogeneity, correlating a cell’s
identity with the modification landscape of its transcripts. These single‑cell
approaches allow questions such as whether a particular modification guides
lineage commitment, mediates stress responses or modulates viral replication to
be addressed directly.
2 Experimental
methodologies for single‑cell RNA modification profiling
The central technical obstacle for
single‑cell epitranscriptomics is the minute amount of RNA available from a
single cell. Methods developed for bulk samples often require microgram
quantities of input and labour‑intensive enrichment steps that are incompatible
with picogram‑scale starting material. To surmount these challenges,
investigators have adapted existing techniques for low input or devised new
strategies that bypass problematic steps altogether. Below, we outline key
approaches for each modification and summarise their advantages and
limitations.
2.1 Detecting
m6A
Antibody‑based enrichment • Early m6A mapping relied on immunoprecipitation
(m6A‑seq/MeRIP‑seq) in which fragmented RNA is incubated with an m6A‑specific
antibody to enrich modified fragments. These methods provided transcriptome‑wide
maps but offered only regional (~100–200 nt) resolution and required
substantial input material. picoMeRIP‑seq optimises recovery from
picogram‑scale input and has enabled profiling in scarce cell types (e.g.,
single oocytes) by minimising losses during purification. scm6A‑seq
takes a multiplexing approach: RNA from individual cells is fragmented, dual‑barcoded
and pooled for a single immunoprecipitation, reducing batch effects and
enabling relative quantification across cells. However, antibody dependence and
coarse resolution remain limitations.
Enzyme‑based detection • The antibody‑free method DART‑seq
(Deamination Adjacent to RNA modification Targets sequencing) uses a fusion
of the m6A‑binding YTH domain with the cytidine deaminase APOBEC1. When
expressed in cells, this fusion enzyme induces C‑to‑U edits adjacent to m6A
sites. These edits manifest as C‑to‑T mutations during sequencing, marking the
modification with single‑base precision. Adaptations such as scDART‑seq
or transgenic DART mice extend this approach to single cells in culture
and in vivo. The main drawbacks are that the fusion protein must be introduced
into the cells and that only m6A sites with nearby cytosines can be detected.
Direct RNA sequencing (DRS) • Oxford Nanopore Technologies’ sequencers
measure ionic current as native RNA passes through a nanopore. Modified bases
alter this current signature, allowing m6A to be detected without
immunoprecipitation or reverse transcription. Machine‑learning models (e.g.,
m6Anet or SingleMod) have been trained to call modifications from these
signals. While DRS provides single‑molecule, single‑base resolution and retains
full‑length transcript information, its application to single cells is
currently hampered by comparatively high input requirements, limited throughput
and higher error rates.
2.2 Detecting
m5C
Bisulfite sequencing • The gold standard for mapping m5C is RNA
bisulfite sequencing (RNA‑BS‑seq). Sodium bisulfite converts unmodified
cytosines to uracil, while methylated cytosines are resistant and remain
unchanged. After reverse transcription and sequencing, genuine m5C sites appear
as cytosines in the reads. The harsh chemical treatment degrades RNA, a serious
problem for single‑cell samples. Variants such as UBS‑seq (Ultrafast
Bisulfite Sequencing) use ammonium bisulfite to shorten reaction times and
reduce degradation, but true single‑cell RNA‑BS‑seq remains a challenge.
Antibody‑based m5C‑RIP‑seq and mechanism‑based approaches like Aza‑IP exist but
suffer from low resolution or only detect targets of specific
methyltransferases.
2.3 Detecting
pseudouridine (Ψ)
CMC‑based chemical labelling • Ψ is traditionally mapped using N‑cyclohexyl‑N′‑(2‑morpholinoethyl)carbodiimide
metho‑p‑toluenesulfonate (CMC). CMC reacts with Ψ to form a bulky adduct that
causes reverse transcriptase to stall one nucleotide downstream. Techniques
such as Pseudo‑Seq and PSI‑seq leverage these termination events to identify Ψ
sites. While single‑base resolution is possible, the protocols require large
amounts of RNA and multiple purification steps, making them incompatible with
single‑cell samples. Recent improvements streamline library construction, but
routine single‑cell detection is not yet feasible.
Cui et al. Sig Transduct Target Ther 7, 334 (2022). |
2.4 Detecting
A‑to‑I editing
A‑to‑I editing, catalysed by ADAR
enzymes, is unique among RNA modifications because it creates a base that base‑pairs
like guanosine. During cDNA synthesis and sequencing, edited positions
therefore appear as A‑to‑G mismatches relative to the reference genome.
In principle, standard scRNA‑seq data contain information on editing events. In
practice, low per‑cell coverage means that very few reads support any given
site. To increase confidence, researchers pool reads from cells of the same
type—creating “pseudo‑bulk” datasets—and use variant calling pipelines to
distinguish true edits from genomic polymorphisms or sequencing errors.
Although this sacrifices single‑cell resolution, it allows cell‑type‑specific
editing patterns to be characterised without specialised library preparation.
Table 1 – Comparison
of methods for single‑cell RNA modification detection
Modification |
Representative
method |
Key
principle |
Strengths |
Limitations |
m6A |
picoMeRIP‑seq |
Antibody enrichment of fragments |
Picogram‑scale input; no genetic
modification required |
Low spatial resolution; antibody
dependency |
m6A |
scm6A‑seq |
Dual barcoding and pooled
immunoprecipitation |
Reduces batch effects; relative
quantification across cells |
Low resolution; complex library
prep |
m6A |
scDART‑seq |
Fusion of m6A reader and cytidine
deaminase induces C‑to‑U edits |
Antibody‑free; single‑base
resolution; compatible with in vivo models |
Requires expression of fusion
protein; only detects sites with nearby cytosines |
m5C |
UBS‑seq |
Bisulfite conversion leaves
methylated Cs untouched |
Single‑base resolution;
established chemistry |
Harsh conditions degrade RNA; high
input requirement |
Ψ |
Pseudo‑Seq/PSI‑seq |
CMC adduct induces reverse‑transcription
stops |
Single‑base resolution |
Requires high RNA input; labour‑intensive;
not yet single‑cell compatible |
A‑to‑I |
scRNA‑seq plus variant calling |
Inosine is read as guanosine |
No special library prep; leverages
existing scRNA‑seq datasets |
Low coverage necessitates pseudo‑bulking;
sensitive to SNP contamination |
3 Computational
pipelines for data analysis
Single‑cell epitranscriptomic
datasets pose unique computational challenges. Unlike conventional scRNA‑seq
data, reads may carry deliberate mismatches (e.g., C‑to‑T conversions in
bisulfite sequencing or DART‑seq) or truncate at modification sites.
Furthermore, the sparse capture of transcripts in single cells results in many
missing values. There is currently no universal pipeline; instead, researchers
assemble bespoke workflows using specialised tools at each step.
3.1 Alignment
and quality control
Aligning reads to a reference genome
is complicated by the presence of systematic mismatches. For bisulfite data,
reference genomes with C‑to‑T conversions are used so that methylated
and unmethylated cytosines align correctly. DART‑seq and similar data require
tolerant alignment settings so that edited bases are not discarded as errors.
Quality control involves standard scRNA‑seq metrics—library size, gene count
per cell, fraction of mitochondrial reads—and modification‑specific metrics
such as bisulfite conversion efficiency. Deduplication using unique molecular
identifiers (UMIs) is essential to obtain accurate modification counts.
3.2 Modification
site calling and quantification
The strategy for identifying
modified sites depends on the experimental design:
- Peak‑based calling – For
enrichment methods (e.g., MeRIP‑seq), algorithms adapted from ChIP‑seq
(such as MACS2) identify peaks where read coverage is enriched over a
control input. Specialised packages like MeTPeak or MeRIPtools
implement statistical tests suited to m6A data.
- Variant‑based calling – For
approaches that induce mutations (A‑to‑I, DART‑seq, bisulfite sequencing),
variant callers are used to detect mismatches at specific positions. Tools
such as scAllele or RESIC work with scRNA‑seq data but still
require pooling across cells for adequate depth.
- Signal‑based calling – For
nanopore DRS, machine‑learning models examine raw ionic current traces to
classify each k‑mer as modified or unmodified. Software like m6Anet,
SingleMod, Tombo or EpiNano are examples in this
rapidly evolving domain.
- Predictive modelling – An
alternative is to infer modification levels from gene expression and
sequence context. Models such as Scm6A and SigRM use
features like the expression of writers, erasers and readers, motif
presence and local sequence composition to predict m6A status. While
indirect, these approaches leverage vast existing scRNA‑seq datasets and
circumvent the need for specialised library preparation.
3.3 Downstream
analysis
Once modifications are called, they
can be integrated into single‑cell analysis frameworks (e.g., Seurat or Scanpy)
as additional “assays” alongside gene expression. Researchers cluster cells
based on their modification profiles, perform trajectory inference to study
dynamic changes and test for differential modification between cell types or
conditions. The sparse and often binary nature of modification data
necessitates new statistical models for differential analysis. Pipelines such
as scDown aim to provide an end‑to‑end workflow, but the field remains
fragmented and rapidly evolving.
Table 2 – Examples
of bioinformatic tools for single‑cell epitranscriptomic analysis
Category |
Tool |
Function/Notes |
Supported
modifications |
Peak calling |
MeTPeak / MeRIPtools |
Identify enriched regions from
antibody‑based data |
m6A (MeRIP‑seq) |
Variant calling |
scAllele, RESIC |
Call SNVs or RNA edits from pooled
scRNA‑seq |
A‑to‑I, DART‑seq, SNPs |
Bisulfite analysis |
MethSCAn |
Analyse single‑cell bisulfite‑seq
(principles extend to RNA‑BS‑seq) |
m5C |
Nanopore analysis |
m6Anet, SingleMod |
Detect modifications from nanopore
current signals |
m6A (and other modifications) |
Predictive modelling |
SigRM, Scm6A |
Infer modification status from
gene expression and sequence |
m6A |
Downstream analysis |
Seurat, Scanpy, scDown |
Clustering, trajectory analysis
and integration |
Any derived modification matrix |
4 Applications
across the tree of life
Epitranscriptomic marks are
conserved across kingdoms, but their functions and regulation are often lineage‑specific.
Single‑cell approaches are uncovering how these modifications contribute to
development, stress responses and host–pathogen interactions in diverse
organisms.
4.1 Animal
systems
Neurobiology – In the mouse brain, scDART‑seq has revealed
cell‑type‑specific m6A landscapes. Microglia display notably low m6A levels
compared with neurons and other glia, and many m6A sites show age‑dependent
dynamics. These findings implicate m6A in neural development and ageing.
Early development – Low‑input methods such as picoMeRIP‑seq and
scm6A‑seq have mapped the dynamic m6A landscape during oocyte maturation and
early embryogenesis. These maps suggest that m6A deposition is tightly
regulated during the earliest cell fate decisions.
Hematopoiesis – By pooling scRNA‑seq reads within clusters,
researchers have identified lineage‑specific A‑to‑I editing patterns in human
haematopoietic stem and progenitor cells. Editing at sites within the
3′ UTR of EIF2AK2 changes as cells commit to different lineages,
hinting at a role for RNA editing in balancing self‑renewal and
differentiation.
4.2 Plants
In plants, m6A influences flowering,
embryogenesis and responses to abiotic stress. Although single‑cell
epitranscriptomic studies in plants remain nascent, the core m6A machinery is
conserved. Interestingly, the m6A consensus motif differs: while mammals often
modify RRACH motifs, plants exhibit a URUAY motif and frequently possess an
expanded repertoire of writer, eraser and reader genes, particularly in long‑lived
tree species. Applying single‑cell methodologies to plant systems is expected
to illuminate how these epitranscriptomic dialects mediate development and
environmental adaptation.
4.3 Host–virus
interactions
Viruses co‑opt and manipulate host
epitranscriptomic machinery to their advantage. Herpesviruses such as
HSV‑1 mislocalise the host m6A writer complex to reduce m6A levels on both
viral and host transcripts, possibly dampening antiviral responses. Flaviviruses
(e.g., Dengue and Zika) have been studied using viscRNA‑Seq, which captures
both host and viral RNA from the same cell; this revealed extreme heterogeneity
in viral load and identified host factors with virus‑specific effects. Coronaviruses,
including SARS‑CoV‑2, decorate their genomes with m6A, pseudouridine and 2′‑O‑methylation
to promote replication and evade innate immunity. Retroviruses such as
HIV‑1 enhance host m6A writer activity, altering m6A patterns on specific host
transcripts and modulating viral replication in a cell‑type‑specific manner.
Single‑cell approaches are essential for dissecting these finely tuned
interactions because viral burden and host responses vary dramatically between
individual cells.
4.4 Microbial
systems
Single‑cell epitranscriptomics in
microbes is technically challenging but offers intriguing insights:
- Bacteria – Lack
of poly(A) tails and overwhelming rRNA content complicate scRNA‑seq.
Specialised protocols like MATQ‑seq and RiboD‑PETRI address these issues.
Initial nanopore studies suggest that m6A on bacterial mRNA is scarce and
may arise from off‑target activity of tRNA/rRNA methyltransferases rather
than regulatory events. However, stress conditions can alter bacterial
modification landscapes, indicating potential roles in adaptation.
- Archaea – Archaea
feature unique modifications (e.g., archaeosine) and complex processing
intermediates in their rRNAs. Nanopore sequencing has mapped many of these
modifications, but the archaeal mRNA epitranscriptome remains largely
unexplored.
- Fungi – Filamentous
fungi perform widespread mRNA A‑to‑I editing using adenosine deaminases
acting on tRNA (ADATs), especially during sexual reproduction. This
editing frequently creates nonsynonymous codon changes and can provide
fitness advantages by producing both edited and unedited protein isoforms.
Combining single‑cell transcriptomics with epitranscriptomic mapping is
beginning to reveal how fungal pathogens coordinate these processes during
host infection.
5 Summary
and outlook
Single‑cell epitranscriptomics has
transitioned from concept to reality thanks to innovations in chemistry,
enzymology and sequencing. These methods reveal cell‑type‑specific and dynamic
patterns of RNA modifications that were invisible in bulk data and are
beginning to illuminate how the epitranscriptome shapes development, ageing and
immune responses. Nonetheless, significant hurdles remain. Sparse transcript
capture forces reliance on pseudo‑bulk strategies that sacrifice true single‑cell
resolution, and no routine single‑cell methods exist for some modifications
(notably pseudouridine). The rapid pace of experimental development has
outstripped progress in bioinformatics, leaving many groups to assemble
ad hoc pipelines.
Looking ahead, the field is likely
to progress along several fronts. Multi‑modal sequencing strategies that
can detect multiple modification types on the same molecule will provide a more
holistic view of RNA regulation. Spatial epitranscriptomics will situate
modification patterns within their tissue context, clarifying how
microenvironment influences the epitranscriptome. CRISPR‑based RNA editing
tools, which fuse programmable Cas proteins to deaminases or
methyltransferases, promise to enable targeted writing or erasing of
modifications, allowing direct tests of causality. As methods mature and become
more accessible, single‑cell epitranscriptomic profiling is poised to deliver
new biomarkers for disease diagnosis, prognostication and therapy monitoring.
References
Birkedal U, Christensen-Dalsgaard M, Krogh N, et al., Profiling of ribose methylations in RNA by high-throughput sequencing, Angewandte Chemie, 2015, https://doi.org/10.1002/anie.201408362
Cusanovich DA, Daza R, Adey A, et al.,
Multiplex single-cell profiling of chromatin accessibility by combinatorial
cellular indexing, Science, 2015, https://doi.org/10.1126/science.aab1601
Dominissini D, Nachtergaele S,
Moshitch-Moshkovitz S, et al., The dynamic N1-methyladenosine
methylome in eukaryotic messenger RNA, Nature, 2016, https://doi.org/10.1038/nature16998
Garcia-Campos MA, Edelheit S, Toth U, et al.,
Deciphering the m6A code via antibody-independent quantitative profiling, Cell, 2019, https://doi.org/10.1016/j.cell.2019.06.013
Jin W, Tang Q, Wan M, et al.,
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE
tissue samples, Nature, 2015, https://doi.org/10.1038/nature15740
Jonkhout N, Tran J, Smith MA, et al.,
The RNA modification landscape in human disease, RNA, 2017, https://doi.org/10.1261/rna.063503.117
Ke S, Alemu EA, Mertens C, et al.,
A majority of m6A residues are in the last exons, allowing the potential
for 3’ UTR regulation, Genes & Development, 2015, https://doi.org/10.1101/gad.269415.115
Lein E, Borm LE, Linnarsson S, The
promise of spatial transcriptomics for neuroscience in the era of molecular
cell typing, Science, 2017, https://doi.org/10.1126/science.aan6827
Li X, Xiong X, Wang K, et al.,
Transcriptome-wide mapping reveals reversible and dynamic N1-methyladenosine methylome, Nature Chemical Biology,
2016, https://doi.org/10.1038/nchembio.2040
Li Y, Wang Y, Vera-Rodriguez M, et al.,
Single-cell m6A mapping in vivo using picoMeRIP–seq, Nature Biotechnology, 2023,
doi:10.1038/s41587-023-01831-7
Limbach PA, Crain PF, McCloskey JA,
Summary: the modified nucleosides of RNA, Nucleic Acids Research,
1994, https://doi.org/10.1093/nar/22.12.2183
Meyer Kate D, Saletore Y, Zumbo P, et al.,
Comprehensive analysis of mRNA methylation reveals enrichment in 3‘UTRs and
near stop codons, Cell, 2012, https://doi.org/10.1016/j.cell.2012.05.003
Meyer KD, DART-seq: an
antibody-free method for global m6A detection, Nature Methods, 2019, https://doi.org/10.1038/s41592-019-0570-0
Molinie B, Wang J, Lim KS, et al., m6A-LAIC-seq reveals the census and complexity of the m6A epitranscriptome, Nature Methods,
2016, https://doi.org/10.1038/nmeth.3898
Mooijman D, Dey SS, Boisset J-C, et al.,
Single-cell 5hmC sequencing reveals chromosome-wide cell-to-cell variability
and enables lineage reconstruction, Nature Biotechnology,
2016, https://doi.org/10.1038/nbt.3598
Muraro MJ, Dharmadhikari G, Grün D, et al.,
A single-cell transcriptome atlas of the human pancreas, Cell Systems, 2016, https://doi.org/10.1016/j.cels.2016.09.002
Peterson VM, Zhang KX, Kumar N, et al.,
Multiplexed quantification of proteins and transcripts in single cells, Nature Biotechnology, 2017, https://doi.org/10.1038/nbt.3973
Ramsköld D, Luo S, Wang YC, et al.,
Full-length mRNA-seq from single-cell levels of RNA and individual circulating
tumor cells, Nature Biotechnology, 2012, https://doi.org/10.1038/nbt.2282
Schaefer M, Kapoor U, Jantsch MF,
Understanding RNA modifications: the promises and technological bottlenecks of
the ‘epitranscriptome’, Open Biology, 2017, https://doi.org/10.1098/rsob.170077
Shinde H, Dudhate
A , Kadam US, Hong JC, RNA methylation in plants: An overview. Frontiers in
Plant Science; https://10.3389/fpls.2023.1132959
Shinde, H. and Kadam US. Growing prospects of RNA therapeutics: A
case of METTL5 and 18S rRNA m6A modification. Molecular Therapy, https://doi.org/10.1016/j.ymthe.2023.12.005
Smallwood SA, Lee HJ, Angermueller C, et al.,
Single-cell genome-wide bisulfite sequencing for assessing epigenetic
heterogeneity, Nature Methods, 2014, https://doi.org/10.1038/nmeth.3035
Squires JE, Patel HR, Nousch M, et al.,
Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA, Nucleic Acids Research, 2012, https://doi.org/10.1093/nar/gks144
Stoeckius M, Hafemeister C, Stephenson W, et
al., Simultaneous epitope and transcriptome measurement in single
cells, Nature Methods, 2017, https://doi.org/10.1038/nmeth.4380
Stubbington MJT, Rozenblatt-Rosen O, Regev A,
et al., Single-cell transcriptomics to explore the immune system in
health and disease, Science, 2017, https://doi.org/10.1126/science.aan6828
Tegowski M, Flamand MN, Meyer KD,
scDART-seq reveals distinct m6A signatures and mRNA
methylation heterogeneity in single cells, Molecular Cell,
2022, https://doi.org/10.1016/j.molcel.2021.12.038
Wang Y, Xiao Y, Dong S, et al.,
Antibody-free enzyme-assisted chemical approach for detection of N6-methyladenosine, Nature Chemical Biology,
2020, https://doi.org/10.1038/s41589-020-0525-x
Wei CM, Gershowitz A, Moss B,
Methylated nucleotides block 5’ terminus of HeLa cell messenger RNA, Cell, 1975, https://doi.org/10.1016/0092-8674(75)90158-0
Yao H, Gao C-C, Zhang D, et al.,
scm6A-seq reveals single-cell landscapes of the dynamic m6A
during oocyte maturation and early embryonic development, Nature Communications, 2023, https://doi.org/10.1038/s41467-023-35958-7
Zhang Z, Chen L-Q, Zhao Y-L, et al.,
Single-base mapping of m6A by an antibody-independent method, Science Advances, 2019, https://doi.org/10.1126/sciadv.aax0250
Zheng GXY, Terry JM, Belgrader P, et al.,
Massively parallel digital transcriptional profiling of single cells, Nature Communications, 2017, https://doi.org/10.1038/ncomms14049
Zhu C, Gao Y, Guo H, et al.,
Single-cell 5-formylcytosine landscapes of mammalian early embryos and ESCs at
single-base resolution, Cell Stem Cell,
2017, https://doi.org/10.1016/j.stem.2017.02.013